Sign Out
Hivent EM: Hypersensitivity to the drug or any of its components.
Thyrotoxicosis.
Threatened abortion during the first and second trimesters of pregnancy. There is no definite proof as to the safety of the drug to the fetus in the early stages of pregnancy.
Hivent DS: Hypersensitivity to any of its components.
Although intravenous salbutamol and occasionally salbutamol tablets are used in the management of premature labor, uncomplicated by conditions such as placenta previa, ante-partum hemorrhage or toxemia of pregnancy, salbutamol presentations should not be used for threatened abortion.
Hivent Plus: It is contraindicated to patients with: Hypersensitivity to any component of the drug product or to atropine and its derivatives.
Hypertrophic obstructive cardiomyopathy or tachyarrhythmia.
